Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers
British Journal of Clinical Pharmacology · 2026-08 · 92 (8) · 2682-2692
DOI: 10.1002/bcp.70548 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 04.04.2026. Verfasst von Vianney Tuloup und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, CHRU Tours, Tours, France. Hauptthemen laut MEDLINE: Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Enzyme Inducers, Models, Biological. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Aims Pharmacokinetic interaction studies typically focus on oral administration, but intravenous (IV) administration bypasses intestinal degradation and hepatic first‐pass metabolism, leading to distinct drug–drug interaction (DDI) magnitude. This study aimed to develop a predictive model for DDIs involving IV‐administered drugs.
Methods
Drugs metabolized by the five major cytochrome P450 enzymes were analysed. Data from IV DDI studies, including area under the concentration‐time curve (AUC) ratios of object drugs with and without precipitants, were collected. A Bayesian approach estimated IV contribution ratios (CR) from published oral CR values. Predictions were validated by assessing whether predicted‐to‐observed ratios fell within 50–200% of observed values.
Results
Data for 33 drugs and 87 AUC ratios involving 26 precipitants were analysed. In the training set, 95% of AUC ratios were within the acceptability range, with a mean bias of 0.09 mg·h/L and 16% imprecision. In the validation set, 85% of predictions were within range, with a bias of −0.012 mg·h/L and 27.3% imprecision. Mean AUC ratios for inhibitors were 2.28 (oral) and 1.78 (IV). For inducers, mean AUC ratios were 0.209 (oral) and 0.62 (IV).
Conclusions
Despite the limited dataset, the model demonstrated robust performance with 85% of predictions validated. It expands the DDI‐predictor framework for quantitative prediction of cytochrome‐mediated drug–drug interactions affecting drug exposure to intravenously administered object drugs, thereby providing a tool to predict and understand IV‐specific DDIs effectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy Department, CHRU Tours, Tours, France.
- Pharmacy Faculty, Tours University, Tours, France.
- Inserm 1327 ISCHEMIA, Tours University, Tours, France.
- Pharmacology-Physiology-Toxicology Department, ISPB Pharmacy Faculty of Lyon, University of Lyon, Lyon, France.
- Laboratoire de Biométrie et Biologie Évolutive, Univ Lyon, Université Claude Bernard Lyon 1, UMR CNRS 5558, Villeurbanne, France.
- Pharmacy Department, University Hospital of Lyon, GH Nord, Lyon, France.
ORCID-Profile: Vianney Tuloup, Michel Tod, Laurent Bourguignon
Zitieren
APA
Tuloup, V., Tod, M., & Bourguignon, L. (2026). Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers. British Journal of Clinical Pharmacology, 92(8), 2682-2692. https://doi.org/10.1002/bcp.70548
Vancouver
Tuloup V, Tod M, Bourguignon L. Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers. British Journal of Clinical Pharmacology. 2026;92(8):2682-2692. doi:10.1002/bcp.70548
BibTeX
@article{Tuloup2026,
author = {Tuloup, Vianney and Tod, Michel and Bourguignon, Laurent},
title = {Quantitative prediction of intravenous drug interactions caused by cytochromes P450 inhibitors and inducers},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
volume = {92},
number = {8},
pages = {2682--2692},
doi = {10.1002/bcp.70548}
}
EUVIMED